Cargando…

Precision medicine: from pharmacogenomics to pharmacoproteomics

Disease progression and drug response may vary significantly from patient to patient. Fortunately, the rapid development of high-throughput ‘omics’ technologies has allowed for the identification of potential biomarkers that may aid in the understanding of the heterogeneities in disease development...

Descripción completa

Detalles Bibliográficos
Autores principales: Chambliss, Allison B., Chan, Daniel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037608/
https://www.ncbi.nlm.nih.gov/pubmed/27708556
http://dx.doi.org/10.1186/s12014-016-9127-8